Halozyme Therap (HALO.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow - Longbridge

Quote List Quote List

Event Tracking

Nov4

Halozyme Therap released FY2025 9 Months earnings on November 3 After-Market EST, actual revenue USD 944.84 M, actual EPS USD 3.69

00:00

Halozyme Therap released FY2025 Q3 earnings on November 3 After-Market EST, forecast revenue USD 339.1M, forecast EPS USD 1.3875

00:00

Oct27

Halozyme Therap to release FY2025 Q3 earnings on November 3 After-Market EST, forecast revenue USD 338.95 M, EPS USD 1.3875

00:16

Aug29

Hedge Fund Recommends Halozyme Therapeutics as a Cheap Biotech Stock

09:00

Aug5

Halozyme Therap released FY2025 Semi-Annual earnings on August 5 After-Market EST, actual revenue USD 590.58 M, actual EPS USD 2.26

23:00

Halozyme Therap released FY2025 Q2 earnings on August 5 After-Market (EST), actual revenue USD 325.72 M (forecast USD 285.92 M), actual EPS USD 1.33 (forecast USD 1.035)

23:00

Schedules & Filings

Schedules

Filings

Nov3

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 354.26 M, Net Income 175.23 M, EPS 1.43

Aug5

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 325.72 M, Net Income 165.16 M, EPS 1.33

May6

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 264.86 M, Net Income 118.1 M, EPS 0.93

View More

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change

View More